ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1723

Clustering Analysis with Unsupervised Machine Learning Process to Phenotype the Cardiovascular Risk of Patients with Rheumatoid Arthritis Beyond the 10-year Prediction Algorithm

Fabio Cacciapaglia1, Vincenzo Venerito2, Gian Luca Erre3, Matteo Piga4, Andreina Manfredi5, Garifallia Sakellariou6, Ombretta Viapiana7, Elisa Gremese8, Elena Bartoloni Bocci9, Francesca Romana Spinelli10 and Fabiola Atzeni11, and "Cardiovascular Obesity and Rheumatic DISeases" Study Group of the Italian Society of Rheumatology, 1Rheumatology Unit DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 2Rheumatology Unit, DiMePRe-J University of Bari, Bari, Italy, 3Rheumatology Unit - University of Sassari, Sassari, Italy, 4Rheumatology Unit - University of Cagliari, Cagliari, Italy, 5University of Modena and Reggio Emilia, Modena, 6Department of Internal Medicine and Medical Therapy, University of Pavia, and Istituti Clinici Scientifici Maugeri IRCCS Pavia,, Pavia, Italy, 7Rheumatology Unit, University of Verona, Verona, Italy, 8Catholic University of the Sacred Heart, Rome, Rome, Italy, 9Rheumatology Unit. Department of Medicine, Perugia, Perugia, Italy, 10Sapienza University of Rome, Rome - Italy, Roma, Rome, Italy, 11University of Messina, Italy, Messina, Italy

Meeting: ACR Convergence 2024

Keywords: Biostatistics, Cardiovascular, health behaviors, Measurement, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Health Services Research I

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Rheumatoid arthritis (RA) patients are at increased cardiovascular (CV) risk, but traditional CV risk factors and available 10-year CV risk estimation models may not correctly intercept high-risk RA patients [1]. Phenotyping patients will likely undergo major cardiovascular events (MACE) is a clinical challenge, and unsupervised machine learning (uML) algorithms could be helpful in clinical practice. This study investigated whether an uML clustering analysis can determine the RA patient’s phenotype with different frequencies of MACE in a large RA cohort.

Methods: A cross-sectional multicentre cohort of RA patients fulfilling the 2010 ACR/EULAR classification criteria, free from previous CV events, was enrolled in January 2019 and longitudinally observed for new onset of MACE for 5 years. Clinical and demographic attributes were recorded, including traditional CV risk factors and the SCORE-2 algorithm [2], and MACE occurrence was tracked. Factor Analysis with Mixed Data (FAMD), a Principal Component Analysis generalization that can be deployed on large datasets with qualitative and quantitative variables, was implemented in a Python ver.3.9 environment using Prince ver. 0.7.1. Observations with missing data were ablated. The number of FAMD components to retain for clustering was assessed using bootstrapped eigenvalues distribution. Hierarchical Clustering on Principal Components was performed to define the number of clusters using Ward’s criterion and an Euclidian distance metric on the selected FAMD principal components. A supervised extreme gradient boosting (XGBoost) algorithm was run with cluster labels as the dependent variable to assess feature importance for cluster categorization. ANOVA and Chi-square were used to determine differences in the continuous and categorical variables distribution between clusters.

Results: Data from 951 RA patients (mean ±SD age 61.8±10.5 years, female 81.1%, and median (95%CI) disease duration of 120 (102-126) months) were analyzed. 18 MACE cases were recorded with an incidence rate of 4.73/1000 patient-years. Hierarchical clustering on two principal components retrieved n.4 clusters (see Figure). Age, disease duration, triglycerides serum level, and SCORE-2 were the most critical factors for clustering. Cluster 1: high HAQ, steroid user, and high total cholesterol values; Cluster 2: long disease duration, high systolic blood pressure, serum triglyceride level, and patients on lipid-lowering agents and TNFi; these patients presented with more MACE. Cluster 3: lower disease activity, BMI, diabetes, hypertension, and SCORE-2; Cluster 4: higher prevalence of male patients with disease < 10 years and on csDMARDs therapy; patients in these clusters did not experience any MACE.

Conclusion: Our uML-derived clustering identified specific clinical features of RA patients to consider together with the SCORE-2 chart. The portrayed disease phenotypes can corroborate CV risk models in recognizing those more likely to experience a MACE.

References:
1. Choy E et al. Rheumatology (Oxford) 2014; 53(12),2143-54
2. SCORE-2 Working Group and ESC CV risk collaboration. Eur Heart J 2021;42:2439-5

Supporting image 1

Figure


Disclosures: F. Cacciapaglia: AbbVie/Abbott, 2, 6, Boehringer-Ingelheim, 2, 6, Eli Lilly, 6, Galapagos, 6, Janssen, 2, 6, Pfizer, 6; V. Venerito: None; G. Erre: None; M. Piga: None; A. Manfredi: None; G. Sakellariou: None; O. Viapiana: None; E. Gremese: None; E. Bartoloni Bocci: None; F. Spinelli: Abbvie, 2, 6, Eli Lilly, 6, Galapagos, 2, GlaxoSmithKlein(GSK), 6, Pfizer, 6; F. Atzeni: None.

To cite this abstract in AMA style:

Cacciapaglia F, Venerito V, Erre G, Piga M, Manfredi A, Sakellariou G, Viapiana O, Gremese E, Bartoloni Bocci E, Spinelli F, Atzeni F. Clustering Analysis with Unsupervised Machine Learning Process to Phenotype the Cardiovascular Risk of Patients with Rheumatoid Arthritis Beyond the 10-year Prediction Algorithm [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clustering-analysis-with-unsupervised-machine-learning-process-to-phenotype-the-cardiovascular-risk-of-patients-with-rheumatoid-arthritis-beyond-the-10-year-prediction-algorithm/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clustering-analysis-with-unsupervised-machine-learning-process-to-phenotype-the-cardiovascular-risk-of-patients-with-rheumatoid-arthritis-beyond-the-10-year-prediction-algorithm/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology